Title :

Clinical utility of biochemical markers for the prediction of COVID-19-related mortality in kidney transplant recipients.

Author(s) :

Caillard, S. [Auteur]
Centre Hospitalier Universitaire [Strasbourg] [CHU Strasbourg]
Chavarot, N. [Auteur]
Institut Necker Enfants-Malades [INEM - UM 111 (UMR 8253 / U1151)]
Francois, H. [Auteur]
CHU Tenon [AP-HP]
Matignon, M. [Auteur]
Institut Mondor de Recherche Biomédicale [IMRB]
Snanoudj, R. [Auteur]
Tourret, J. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Greze, C. [Auteur]
Thaunat, O. [Auteur]
Service de Néphrologie [Lyon]
Hôpital Edouard Herriot [CHU - HCL]
Université Claude Bernard Lyon 1 [UCBL]
Frimat, L. [Auteur]
Centre d'investigation clinique - Epidémiologie clinique [Nancy] [CIC-EC]
Service de Néphrologie [CHRU Nancy]
Westeel, P. F. [Auteur]
Université de Picardie Jules Verne [UPJV]
Gatault, P. [Auteur]
CHU Trousseau [Tours]
Transplantation, Immunologie, Inflammation [Tours] [T2i]
Masset, C. [Auteur]
Centre Hospitalier Universitaire de Nantes = Nantes University Hospital [CHU Nantes]
Blancho, G. [Auteur]
Legris, T. [Auteur]
Centre de néphrologie et transplantation rénale [Hôpital de la Conception - APHM]
Moal, V. [Auteur]
Kamar, N. [Auteur]
Département de Néphrologie et Transplantation d'organes [CHU Toulouse]
Jdidou, M. [Auteur]

Néphrologie [CHU Bicêtre]
Colosio, C. [Auteur]
Université de Reims Champagne-Ardenne [URCA]
Mousson, C. [Auteur]
Service de néphrologie (CHU de Dijon)
Goutadier, V. [Auteur]
CHU Montpellier = Montpellier University Hospital
Sicard, A. [Auteur]
Bertrand, D. [Auteur]
Bamoulid, J. [Auteur]
Malvezzi, P. [Auteur]
Couzi, L. [Auteur]
Chemouny, J. M. [Auteur]
Duveau, A. [Auteur]
Mariat, C. [Auteur]
Rerolle, J. P. [Auteur]
Thierry, A. [Auteur]
Bouvier, N. [Auteur]
Anglicheau, D. [Auteur]
Le Meur, Y. [Auteur]
Hazzan, Marc [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Journal title :

Kidney International Reports

Abbreviated title :

Kidney Int Rep

Publication date :

2021-07-21

ISSN :

2468-0249

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Coronavirus disease−2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a significant threat for patients with pre-existing renal disease, including kidney transplant recipients ...
Show more >Coronavirus disease−2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a significant threat for patients with pre-existing renal disease, including kidney transplant recipients (KTRs).1, 2, 3,S1,S2 Although there is ample literature to suggest a role for kidney impairment in the severity of COVID-19, its clinical course in KTRs can vary widely, from minimal symptoms to life-threatening illness. Much of the recent focus in COVID-19 research has revolved around predictors of death and severe disease. Several studies in the adult general population have found an association between elevation of cardiac injury, coagulation, and inflammatory biomarkers and COVID-19−related mortality.4, 5, 6,S3 Nevertheless, only a limited number of single-center studies7,S4 have specifically explored the clinical utility of circulating biomarkers for the prediction of COVID-19−related mortality in solid organ transplant recipients (see Azzi et al.8 for a recent review). By taking advantage of data from a French nationwide registry of KTRs with COVID-19, we sought to investigate the prognostic significance of increased biomarkers of cardiac injury, coagulation, and inflammation in this population.Show less >

Language :

Anglais

Peer reviewed article :

Oui

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

Université de Lille
Inserm
CHU Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Submission date :

2024-01-12T06:24:40Z
2024-02-27T11:27:45Z